{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "61958-2201",
      "generic_name": "Velpatasvir and Sofosbuvir",
      "labeler_name": "Gilead Sciences, Inc.",
      "brand_name": "Epclusa",
      "active_ingredients": [
        {
          "name": "VELPATASVIR",
          "strength": "100 mg/1"
        },
        {
          "name": "SOFOSBUVIR",
          "strength": "400 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "61958-2201-1",
          "description": "28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-2201-1)",
          "marketing_start_date": "20160628",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Gilead Sciences, Inc."
        ],
        "rxcui": [
          "1799212",
          "1799218",
          "2288814",
          "2288816",
          "2584196",
          "2584199",
          "2584200",
          "2584201"
        ],
        "spl_set_id": [
          "7f30631a-ee3b-4cfe-866b-964df3f0a44f"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000191493",
          "N0000191258",
          "N0000191256",
          "N0000190113",
          "N0000185503",
          "N0000190107",
          "N0000190108",
          "N0000190109"
        ],
        "pharm_class_epc": [
          "Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]",
          "Hepatitis C Virus NS5A Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "RNA Replicase Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
          "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
          "Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]"
        ],
        "unii": [
          "WJ6CA3ZU8B",
          "KCU0C7RS7Z"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "4e28b652-df20-450d-9f6e-4cc6e355e223",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20160628",
      "product_id": "61958-2201_4e28b652-df20-450d-9f6e-4cc6e355e223",
      "application_number": "NDA208341",
      "brand_name_base": "Epclusa",
      "pharm_class": [
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Hepatitis C Virus NS5A Inhibitor [EPC]",
        "Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]",
        "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
        "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
        "Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]",
        "P-Glycoprotein Inhibitors [MoA]",
        "RNA Replicase Inhibitors [MoA]"
      ]
    }
  ]
}